Mia's Feed
Medical News & Research

Stenting Enhances Long-Term Survival in Patients with Complete Coronary Blockages Undergoing PCI

Stenting Enhances Long-Term Survival in Patients with Complete Coronary Blockages Undergoing PCI

Share this article

1 min read

Recent findings presented at the SCAI 2025 Scientific Sessions highlight the significant benefits of stenting during chronic total occlusion (CTO) percutaneous coronary intervention (PCI). In patients with complete coronary artery blockages, the use of stents was associated with improved long-term outcomes, including a reduced risk of death from cardiovascular causes at six months and fewer cardiac arrests at one year. The study analyzed 677 patients at a high-volume PCI center, with 81.2% receiving stents. While short-term outcomes such as 30-day mortality and in-hospital complications showed no significant difference, the long-term data strongly suggest that stenting plays a crucial role in enhancing patient survival and reducing adverse cardiac events. As coronary artery disease remains the leading cause of death worldwide, these insights support incorporating stenting into treatment strategies for CTO cases. The study, led by Dr. M Chadi Alraies, emphasizes that stenting is not only safe but also potentially vital for improving patient prognosis following complex coronary interventions. Further research is encouraged to refine treatment approaches and optimize outcomes for patients with CTO.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Technique Identifies Aged Cells Using Electric Fields, Advancing Aging Research

A groundbreaking, label-free technique using electric fields enables quick identification of senescent cells, opening new avenues in aging research and regenerative medicine.

Potential Increase in Obamacare Premiums Expected in Florida Next Year

Expect a major rise in Obamacare premiums in Florida next year as pandemic-era subsidies expire, potentially affecting millions of low- and middle-income enrollees. Learn about the implications for healthcare costs and access.

Innovative Therapy Shows Promise for Rare ALS Treatment

A groundbreaking experimental drug shows promising results in treating a rare, genetically driven form of ALS, highlighting hope for functional recovery and disease modification.